
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ASND] Ascendis Pharma A/S
Data updated 2025-May-01 (Thursday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-May-01 Thursday
Open | $171.00 | High | $173.00 +1.17% |
---|---|---|---|
Close | $167.47 | Low | $164.52 -3.79% |
Volume | 927 Thousand 0.86x | Volatility | 5.15% |
Change |
$-2.97
-1.74%
|
Streak | ↓ 1 days -1.74% |
20d SMA | $155.37 +7.8% | 50d SMA | $155.26 +7.9% | 100d SMA | $144.21 +16.1% | 200d SMA | $138.39 +21.0% |
RSI | 61 | MACD | 1.42 | ADX | 17.4 | Stochastic Oscillator | 91.5 93.6 |
CCI | 106.9 | ATR | 8.23 | OBV | 15.5 Million | Chaikin A/D | 26.4 Million |
Market Cap | 8.28 B | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 28.6 | Price/Book (mrq) | EV/Revenue (ttm) | 32 | EV/EBITDA (ttm) | -20.8 | |
% Held by Insiders | 0.76% | % Held by Institutions | 107.83% | Shares Short | 2.94 M | Shares Short (prior month) | 2.97 M |
Short Ratio | 8.77 | Short % of Outstanding | 5.19% | Short % of Float | 5.24% | Shares Short Change (mom) | -1.0% |
Revenue/Share (ttm) | $4.74 | Profit Margin (ttm) | -180.51% | Operating Margin (ttm) | -26.59% | EBITDA (ttm) | -449 M |
Diluted EPS (ttm) | $-9.26 | Current Ratio (mrq) | 3.56 | Return on Assets (ttm) | -29.73% | Return on Equity (ttm) | -818.43% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 501.40% | Operating Cash Flow (ttm) | -467 M | Free Cash Flow (ttm) | -318 M | |
Choose view type
Daily Performance for Ascendis Pharma A/S. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Ascendis Pharma A/S up to close of 2025-May-01 at $167.47
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+4.38%
|
-3.2%
|
+6.2%
|
9.7%
|
+0.5%
|
+0.6%
|
0.86x
|
02 Trailing 10-days
|
|
+5.89%
|
-3.2%
|
+9.3%
|
12.9%
|
+2.3%
|
+2.5%
|
0.99x
|
03 Trailing 20-days
|
|
+10.07%
|
-3.2%
|
+35.0%
|
39.4%
|
+7.8%
|
+4.9%
|
1.17x
|
04 Trailing 30-days
|
|
+0.86%
|
-3.2%
|
+35.0%
|
39.4%
|
+7.0%
|
+6.5%
|
1.04x
|
05 Trailing 50-days
|
|
+7.97%
|
-3.2%
|
+35.0%
|
39.4%
|
+7.9%
|
+9.0%
|
1.04x
|
06 Trailing 100-days
|
|
+27.83%
|
-3.2%
|
+41.9%
|
46.6%
|
+16.1%
|
+13.6%
|
0.92x
|
07 Trailing 200-days
|
|
+22.21%
|
-3.2%
|
+50.8%
|
55.7%
|
+21.0%
|
+18.8%
|
1.05x
|
08 Month-to-date
|
|
-1.74%
|
-3.2%
|
+1.8%
|
5.2%
|
|
|
|
09 Quarter-to-date
|
|
+7.45%
|
-3.2%
|
+35.0%
|
39.4%
|
|
|
|
10 Year-to-date
|
|
+21.65%
|
-3.2%
|
+41.9%
|
46.6%
|
|
|
|
11 Trailing 52-weeks
|
|
+18.76%
|
-3.2%
|
+50.8%
|
55.7%
|
|
|
|
1-year Performance Benchmarks for Ascendis Pharma A/S:
Related to Ascendis Pharma A/S
Information for Ascendis Pharma A/S
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-01 on Google
SEC Reports : Quarterly reports around 2025-May-01 on SEC Edgar
Compare Ascendis Pharma A/S with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ascendis Pharma A/S
Industry : Pharmaceuticals industry performance which includes Ascendis Pharma A/S